Real-World Emulation of the SWEFOT Trial

NCT05051137 · clinicaltrials.gov ↗

COMPLETED

Status

509

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: Infliximab
DRUG: Sulfasalazine + Hydroxychloroquine

Sponsor

Karolinska Institutet

Collaborators

[object Object]